Receptor News and Research

RSS

Researchers identify, validate three distinct molecular subtypes of prostate cancer

In the largest study of its kind to date, researchers have identified and validated three distinct molecular subtypes of prostate cancer that correlate with distant metastasis-free survival and can assist in future research to determine how patients will respond to treatment, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis announced today that the US Food and Drug Administration has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes.

24 Sep 2016

New study to examine effectiveness of orally administered drug in treating stuttering

Stuttering, an interruption in the flow of speech, affects about three million Americans. It begins most often in childhood, affecting four men for every woman. A precise cause of this complex communicative disorder is not known.

23 Sep 2016

Ludwig researchers shed more light on key requirement for function of regulatory T cells

A Ludwig Cancer Research study published online September 5th in Nature Immunology illuminates a key requirement for the function of regulatory T cells—immune cells that play a critical role in many biological processes, from suppressing inflammation and deadly autoimmunity to helping tumors evade immune attack.

23 Sep 2016

CUMC researchers uncover new details of intracellular channel that controls skeletal muscle

Using high-resolution electron microscopy, Columbia University Medical Center researchers have uncovered new details of the structure and function of an intracellular channel that controls the contraction of skeletal muscle.

22 Sep 2016

Color-deficiency or color-blindness?

Color blindness could be considered a bit of a misleading term, because there are very few people who can't see color at all. Most people have what we call color deficiency or color confusion, which means that they're not blind to color; they just see a reduced number of colors.

From Vision Express 22 Sep 2016

Duke researchers discover blood markers linked to drug-resistant tumor cells

While searching for a non-invasive way to detect prostate cancer cells circulating in blood, Duke Cancer Institute researchers have identified some blood markers associated with tumor resistance to two common hormone therapies.

21 Sep 2016

Researchers propose new explanation for symptoms of fragile X syndrome

Until recently, scientists thought they understood one of the underlying causes of fragile X syndrome, the most common inherited cause of intellectual disability in the United States.

20 Sep 2016

Researchers reveal previously unknown role of glutamate in neuromuscular development

For decades, scientists thought acetylcholine was the only neurotransmitter responsible for controlling how muscles and nerves are wired together during development.

20 Sep 2016

Benefits of cardioprotective drugs may extend beyond preventing acute coronary syndromes

Medications prescribed to prevent heart attacks such as statins and aspirin are also associated with reduced heart attack severity, according to research published in PLOS ONE.

19 Sep 2016

Clinical scientists find new way to treat hypertension

A team of clinical scientists at the University of Bristol have found a new way to treat high blood pressure (hypertension).

16 Sep 2016

Study may help reassure women who fear endometrial side effects of breast cancer drug

A study led by Loyola Medicine researchers may help reassure patients who worry the breast cancer drug tamoxifen could increase their risk of uterine cancer.

16 Sep 2016

UC Irvine study shows how YHS effectively treats different forms of pain

Root extracts from the flowering herbal plant Corydalis yanhusuo, or YHS, has widely used for centuries as a pain treatment. Yet few studies have investigated how it works on different forms of pain, and little is known about its molecular mechanisms.

14 Sep 2016

Study identifies new gene that suppresses breast cancer in mice

In recent years, the incidence of breast cancer has been increasing worldwide, and breast cancer is becoming a serious object of public concern.

13 Sep 2016

Gut microbiota may play role in influencing food allergies

Countless microorganisms live in the intestinal tract. Researchers at the Technical University of Munich (TUM) have been able to demonstrate that intestinal bacteria also play a role in determining the strength of anaphylactic reactions to food allergens.

13 Sep 2016

International researchers discover 44 novel gene sites linked to hypertension

In papers receiving advance online publication in Nature Genetics, two international multi-institutional research teams describe identifying a total of 44 novel gene sites associated with hypertension or high blood pressure.

13 Sep 2016

Study provides insight into how weight-loss drug acts in the brain

A weight-loss drug dampened the response to food cues in regions of the brain associated with attention and emotion, leading to decreases in caloric intake, weight and body mass index (BMI), a team led by scientists at Beth Israel Deaconess Medical Center reported.

12 Sep 2016

Cone snail venom could hold key to efficient therapies for diabetes

New research has found that venom extracted from a species of marine cone snail could hold the key to developing 'ultra-fast-acting' insulins, leading to more efficient therapies for diabetes management.

12 Sep 2016

First accurate simulation reveals how virus shape changes when invading host cell

For the first time, scientists know what happens to a virus' shape when it invades a host cell, thanks to an experiment by researchers at Penn State College of Medicine and University of Pittsburgh School of Medicine.

12 Sep 2016

Using the immune system to fight cancer: an interview with Dr Charles Akle

We all produce as many as 100,000 different types of cancer cells every day, which are recognized and eliminated by our extraordinarily efficient immune system. However, if something goes wrong with the immune system, and it no longer gets rid of these cells, then that’s when cancerous cells grow and become a problem.

12 Sep 2016

Receptor News and Research

Researchers identify, validate three distinct molecular subtypes of prostate cancer

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

New study to examine effectiveness of orally administered drug in treating stuttering

Ludwig researchers shed more light on key requirement for function of regulatory T cells

CUMC researchers uncover new details of intracellular channel that controls skeletal muscle

Color-deficiency or color-blindness?

Duke researchers discover blood markers linked to drug-resistant tumor cells

Researchers propose new explanation for symptoms of fragile X syndrome

Researchers reveal previously unknown role of glutamate in neuromuscular development

Benefits of cardioprotective drugs may extend beyond preventing acute coronary syndromes

Clinical scientists find new way to treat hypertension

Study may help reassure women who fear endometrial side effects of breast cancer drug

UC Irvine study shows how YHS effectively treats different forms of pain

Study identifies new gene that suppresses breast cancer in mice

Gut microbiota may play role in influencing food allergies

International researchers discover 44 novel gene sites linked to hypertension

Study provides insight into how weight-loss drug acts in the brain

Cone snail venom could hold key to efficient therapies for diabetes

First accurate simulation reveals how virus shape changes when invading host cell

Using the immune system to fight cancer: an interview with Dr Charles Akle

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News